Compagnie Lombard Odier SCmA’s Idexx Laboratories IDXX Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-610	Closed	-$249K	–	652
2022 Q4	$249K	Buy	+610	New	+$237K	0.01%	265
2021 Q2	–	Sell	-40	Closed	-$22.1K	–	653
2021 Q1	$20K	Hold	40	–	–	﹤0.01%	576
2020 Q4	$20K	Hold	40	–	–	﹤0.01%	500
2020 Q3	$16K	Hold	40	–	–	﹤0.01%	459
2020 Q2	$13K	Sell	40 -360	-90%	-$104K	﹤0.01%	467
2020 Q1	$97K	Hold	400	–	–	﹤0.01%	301
2019 Q4	$104K	Hold	400	–	–	﹤0.01%	309
2019 Q3	$109K	Buy	+400	New	+$111K	﹤0.01%	300

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Compagnie Lombard Odier SCmA's IDXX Position: Q1 2023 in Review

Compagnie Lombard Odier SCmA sold out of Idexx Laboratories (IDXX) in Q1 2023, closing a stake of 610 shares — an estimated $249K sold.

Compagnie Lombard Odier SCmA first reported a position in IDXX in Q3 2019 and held it in 8 quarters. The position peaked at $249K in Q4 2022. 1,055 funds tracked by Wall St. Rank hold IDXX as of Q1 2023.

Compagnie Lombard Odier SCmA reported no remaining Idexx Laboratories position as of Q1 2023 after selling out during the quarter.
Compagnie Lombard Odier SCmA sold 610 Idexx Laboratories shares in Q1 2023, an estimated $249K.
Compagnie Lombard Odier SCmA first reported a position in Idexx Laboratories in Q3 2019 and held it in 8 quarters.
Compagnie Lombard Odier SCmA's Idexx Laboratories position peaked at $249K in Q4 2022.
1,055 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2023.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2023, filed 1 May 2023.